| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007032396A1 Therapeutic agent for spinal cord injury |
| 03/22/2007 | WO2007032255A1 T-cell receptor and nucleic acid encoding the receptor |
| 03/22/2007 | WO2007031727A2 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 03/22/2007 | WO2007031590A1 Method for the in vitro detection of a predisposition to the development of alterations in ovarian function |
| 03/22/2007 | WO2007031091A2 Rna antagonist compounds for the modulation of p21 ras expression |
| 03/22/2007 | WO2006130581A3 Methods for delivering genes |
| 03/22/2007 | WO2005111220A3 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
| 03/22/2007 | WO2005060536A3 si-RNA-MEDIATED GENE SILENCING TECHNOLOGY TO INHIBIT TYROSINASE AND REDUCE PIGMENTATION |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066935 Needleless syringe having medical agent accomodated therein |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066558 Molecular determinants of myeloma bone disease and use thereof |
| 03/22/2007 | US20070066557 Modulation of glucocorticoid receptor expression |
| 03/22/2007 | US20070066556 Antisense antiviral compound and method for treating picornavirus infection |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066552 Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids |
| 03/22/2007 | US20070066551 Aptamer medicinal chemistry |
| 03/22/2007 | US20070066550 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/22/2007 | US20070066549 Modified antisense oligonucleotide; antitumor and anticancer agents |
| 03/22/2007 | US20070066548 Globin variant gene methods and compositions |
| 03/22/2007 | US20070066547 Ligands |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070066522 Tumor inhibition by modulating sprouty expression or activity |
| 03/22/2007 | US20070066521 Short RNA-binding proteins |
| 03/22/2007 | US20070066519 Use of human growth hormone in multiple system atrophy |
| 03/22/2007 | US20070066518 Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same |
| 03/22/2007 | US20070065931 use in modulation of gene expression in plant cells; use in optimizing crop traits such as nutritional value, disease resistance, herbicide resistance; agronomics |
| 03/22/2007 | US20070065925 Vaccine containing cell transformed with a nucleotide sequence of the genome of Porcine circovirus type B |
| 03/22/2007 | US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065848 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 03/22/2007 | US20070065810 Diagnosis and treatment of cervical cancer |
| 03/22/2007 | US20070065804 Method for PR-39 peptide mediated selective inhibition of IkappaBalpha degradation |
| 03/22/2007 | US20070065499 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/22/2007 | US20070065457 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065450 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 03/22/2007 | US20070065449 Method of treating cancer, especially soft tissue sarcoma utilizing gemcitabine in combination with docetaxel and anti-VEGF therapy (bevacizumab) |
| 03/22/2007 | US20070065448 Methods and compositions for treating diseases targeting MABA1 |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065438 Methods of inducing and maintaining immune tolerance |
| 03/22/2007 | US20070065432 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 03/22/2007 | US20070065422 Induction of immune tolerance by sertoli cells |
| 03/22/2007 | US20070065421 Inducing expression of puma to reduce joint inflammation in the treatment of arthritis |
| 03/22/2007 | US20070065412 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes |
| 03/22/2007 | US20070065411 Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065409 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 03/22/2007 | US20070065408 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 03/22/2007 | US20070065389 Cosmetic or therapeutic treatment for white hair or stimulating natural pigmentation; administering polynucleotide fragment |
| 03/21/2007 | EP1764109A1 Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1763538A2 Genetically engineered cells for therapeutic applications |
| 03/21/2007 | EP1702072A4 Genetic therapy and genetic modification using neocentromeric minichromosomes |
| 03/21/2007 | EP1692153A4 Inhibition of syk kinase expression |
| 03/21/2007 | EP1467711B1 Dna dosage forms |
| 03/21/2007 | EP1409014B1 Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virus |
| 03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
| 03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 03/21/2007 | EP1334195B1 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases |
| 03/21/2007 | EP1292327B1 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 03/21/2007 | EP1038025B1 Genetic alterations associated with cancer |
| 03/21/2007 | EP0966532B1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 03/21/2007 | CN1934256A Decoy nucleic acid to synoviolin gene promoter |
| 03/21/2007 | CN1934253A Subgroup B adenoviral vectors for treating disease |
| 03/21/2007 | CN1934123A Intracellular delivery of osteoinductive proteins and peptides |
| 03/21/2007 | CN1932017A Tumor adoptosis inducing ligandin and its application in preparing antitumor medicine |
| 03/21/2007 | CN1931373A Correlation of cofilin 1 and resistance to anticancer taxane chemotherapy medicine |
| 03/21/2007 | CN1931372A Brain targeting gene transfer and release system and its prepn process |
| 03/21/2007 | CN1931371A Application of siRNA suppressing human Ezrin gene expression in the research on esophagus carcinoma proliferation |
| 03/21/2007 | CN1931365A Hcv e1e2 vaccine compositions |
| 03/21/2007 | CN1305932C Carbohydrate-modified polymers, compositions and uses related thereto |
| 03/21/2007 | CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 03/20/2007 | US7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 03/20/2007 | US7192935 Expression vectors, polypeptides or antibodies; gastrointestinal disorders; treating or preventing lymphadenopathy associated virus or human T-cell leukemia/lymphoma virus (HIV) |
| 03/20/2007 | US7192933 Use of a baculovirus to express an exogenous gene in a mammalian cell |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192927 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 03/20/2007 | US7192773 Gene expression; transforming nucleic acid; antiepileptic agents; antiarrhythmia agent |
| 03/20/2007 | US7192754 Nomuraeae rileyi-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 03/20/2007 | US7192741 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192706 Growth regulating proteins |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192594 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192580 Purging of cells using viruses |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | US7192576 neurotrophic activity; expression vector; facilitates proliferation, differentiation and/or survival of a cell |
| 03/15/2007 | WO2007030820A2 Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists |
| 03/15/2007 | WO2007030691A2 Antisense antiviral compound and method for treating picornavirus infection |
| 03/15/2007 | WO2007030602A2 Treatment of b cells with il-21 and b cell activators induces granzyme b production |
| 03/15/2007 | WO2007030576A2 Antisense antiviral compound and method for treating picornavirus infection |